334 related articles for article (PubMed ID: 8938189)
1. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
Branch AD
Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
[TBL] [Abstract][Full Text] [Related]
2. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
Orum H; Wengel J
Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide derivatives as gene-targeted drugs.
Knorre DG; Vlassov VV
Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
[TBL] [Abstract][Full Text] [Related]
5. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of oncogene expression.
Neckers L; Whitesell L; Rosolen A; Geselowitz DA
Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
[TBL] [Abstract][Full Text] [Related]
7. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
Jen KY; Gewirtz AM
Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
[TBL] [Abstract][Full Text] [Related]
8. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
9. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bacterial RNase P RNA as a drug target.
Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
[TBL] [Abstract][Full Text] [Related]
13. Selective binding of trisamine-modified phosphorothioate antisense DNA to target mRNA improves antisense activity and reduces toxicity.
Matsukura M; Okamoto T; Miike T; Sawai H; Shinozuka K
Biochem Biophys Res Commun; 2002 May; 293(5):1341-7. PubMed ID: 12054660
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligodeoxynucleotide and ribozyme design.
Probst JC
Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
16. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
17. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
18. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
20. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
Delihas N; Rokita SE; Zheng P
Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
